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AbstrACt
background Acute myocardial infarction (AMI) is a 
leading cause of death globally. Increase in AMI mortality 
during winter has also been identiied in existing literature. 
This has been associated with low outdoor and indoor 
temperatures and increasing age. The relationship 
between AMI and other factors such as gender and 
socioeconomic factors varies from study to study. Inluenza 
epidemics have also been identiied as a contributory 
factor.
Objective This paper aims to illustrate the seasonal 
trend in mortality due to AMI in England and Wales with 
emphasis on excess winter mortality (EWM).
Methods Monthly mortality rates per 10 000 population 
were calculated from data provided by the UK Ofice for 
National Statistics (ONS) for 1997–2005. To quantify the 
seasonal variation in winter, the EWM estimates (EWM, 
EWM ratio, Excess Winter Mortality Index) for each year 
were calculated. Negative binomial regression model was 
used to estimate the relationship between increasing age 
and EWM.
results The decline in mortality rate for AMI was 6.8% 
yearly between August 1997 and July 2005. Signiicant 
trend for reduction in AMI-associated mortality was 
observed over the period (p<0.001). This decline was 
not seen with EWM (p<0.001). 17% excess deaths were 
observed during winter. This amounted to about 20 000 
deaths over the 8-year period. Increasing winter mortality 
was seen with increasing age for AMI.
Conclusion EWM secondary to AMI does occur in 
England and Wales. Excess winter deaths due to AMI have 
remained high despite decline in overall mortality. More 
research is needed to identify the relationship of sex, 
temperature, acclimatisation, vitamin D and excess winter 
deaths due to AMI.
bACkgrOund 
Studies over time have observed an increase 
in mortality rate during winter months.1–3 
This appears to be a global phenomenon with 
evidence of excess winter mortality occur-
ring in a number of countries, including the 
UK,4 5 Japan,6 Brazil,7 Canada,2 the USA3 and 
New Zealand.8 
The relationship between mortality and 
temperature observes a U shape9: an increase 
in mortality is seen with extremes in tempera-
ture. Excess winter mortality which is defined 
as ‘a significant increase in the number of 
deaths during winter compared with the 
average of the non-winter seasons’ has been 
linked to the drop in temperature.10 Low 
temperatures have been implicated in the 
increase in number of deaths during the 
winter months; however, they are not due to 
hypothermia. There is evidence to suggest 
that low temperatures trigger pathological 
mechanisms that lead to increase in blood 
strengths and limitations of this study
 Ź The data used involved a large sample size, and 
this was able to capture relevant results in the data 
analysis and this data represents the population of 
interest.
 Ź The paper uses statistical methods that have been 
veriied to analyse trends in mortality as well as to 
deine the concept of excess winter mortality. The 
data analysis was thorough, standardising the out-
comes and presenting the data in a way that can be 
comparable with various populations.
 Ź Although the data provided by the Ofice for National 
Statistics was complete and considered accurate, 
the data characteristics, however, restricted the 
number of variables that could be controlled such as 
sex distribution. To reach a more robust conclusion, 
it would have been necessary to have data to test 
for effects of housing, indoor temperatures, outdoor 
temperatures, inluenza epidemics and other possi-
ble confounders.
 Ź The population data which were used as denomi-
nator would reduce in accuracy as the year of study 
moved away from the recent census (29 April 2001). 
This is because the mid-year populations after this 
date were extrapolated using birth and death data; 
these data are prone to their own type of error. 
However, it is anticipated that the brief period used 
in the research was unlikely to experience any dra-
matic changes in population.
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pressure and thrombus formation.2 The consequence of 
this is the initiation of physiological stress that results in 
the development of a myocardial infarction or a stroke. 
A study involving data from various countries in Europe 
found a similar association but also identified 18°C as the 
threshold for this to occur.11 Research carried out in Scot-
land12 and England13 could quantify this relationship: a 
1°C drop in temperature resulted in a 1%–2% increase 
in the number of deaths. This corresponds to increased 
odds of dying during the winter by 1.5%.10
The effects of temperature are both direct and imme-
diate. Time series analyses have shown that there is a 
minimum lag time of about 24 hours between drop in 
temperature and increase in mortality.14 The impact of 
cold temperature could also extend over a period of 1–2 
weeks. This lag time shows that there is a possible mech-
anism that is initiated by the low outdoor temperatures 
directly that leads to death supporting evidence from 
previous studies. It has also been shown that the effect of 
temperature is significantly potentiated by high relative 
humidity and strong winds.15
There are suggestions that the influence of winters and 
low temperatures on the increase in mortality rates is 
preventable. This is because there is ecological evidence 
that countries with colder winters do not have greater 
excess winter mortality when compared with coun-
tries with milder winters,4 for example, the UK when 
compared with Scandinavian countries.16 17 This observa-
tion is referred to as the excess winter paradox.
Housing insulation and the concept of fuel poverty, 
both of which affect the indoor temperature, are some 
of the factors thought to be responsible for the paradox. 
Houses in Britain have lower insulation properties 
compared with houses in Germany, Russia or the Scan-
dinavian countries.18 Due to the low insulation proper-
ties of houses in England and Wales, it is more expensive 
to warm these homes when compared with houses in 
other European states. This introduces the concept of 
fuel poverty. Fuel poverty is defined as a situation ‘when 
in order to heat its home to an adequate standard of warmth 
a household needs to spend more than 10% of its income on 
total fuel use’.19 The WHO’s recommendation of adequate 
standard warmth is defined as 18°C in occupied rooms 
and 21°C in living room. The temperature level of 18°C is 
remarkable because below this threshold has been iden-
tified as when significant mortality occurs. The ability to 
generate heat to a surrounding temperature above this 
identified threshold might prove necessary. A behavioural 
component may also be contributory to the paradox. For 
example, people living in warmer winters, such as in the 
UK and Portugal, were less likely to heat the living and 
bedroom to recommended levels when outdoor tempera-
ture drops.11 This is a marked contrast to persons leaving 
in countries like Russia20 who maintained their indoor 
temperatures at 20.9°C and 24.2°C when the temperature 
outside was 7°C. Studies also show that people in the UK 
were also less likely to wear protective clothing such as 
hats, heavy jackets and gloves.11 The UK Government has 
acknowledged that excess winter mortality is a problem 
and currently has put in place policies to tackle this 
phenomenon.
Other factors that are considered to play a role in excess 
winter mortality include socioeconomic status,17 influ-
enza,21 22 age16 and vitamin D deficiency. 25-Hydroxyvi-
tamin D [25(OH)D] levels <20 ng/mL is considered an 
independent additional risk factor for acute myocardial 
infarction (AMI)23 24 and is not just a reflection of poor 
health. Dietary sources of vitamin D are usually insuffi-
cient, and deficiency occurs with inadequate sun expo-
sure. Seasonality in 25(OH)D levels have been observed 
and levels are usually lower around winter,23 25 creating 
an extra burden on the cardiovascular system by various 
postulated mechanisms leading to significant coro-
nary artery disease26 and poor collateral circulation.27 
This seasonality is attributed to variability in ultravio-
let-B (UVB) exposure during the seasons.28 There is the 
suggestion that correction of vitamin D deficiency may 
reduce the cardiovascular risk.
There are few studies that have examined the phenom-
enon of excess winter mortality specifically due to AMI 
in England and Wales. Most studies treat the subject 
of excess winter mortality by assessing total mortality 
without isolating individual diagnosis. Assessing indi-
vidual diseases might produce stronger evidence on the 
impact seasonal variation on a particular disease condi-
tion. Due to the overwhelming global impact of this 
condition, it is important to identify seasonal variation of 
mortality due to AMI and also points of possible preven-
tive strategies that can help in reducing the incidence of 
the disease.
MethOdOlOgy
This study was a secondary data analysis that assessed 
excess winter deaths due to AMI in England and Wales. 
The study used anonymised mortality data provided by 
the Office for National Statistics (ONS), UK, and mean 
monthly temperature data provided by the Meteoro-
logical Office, UK. The database provided by the ONS 
consisted of anonymised data of daily mortality in England 
and Wales for the period from 1997 to 2005. The Interna-
tional Classification of Disease (ICD) was used for coding 
the various cause of death. The ninth edition (ICD-9) was 
used from 1997 to 2000 while the tenth edition (ICD-10) 
was used between 2001 and 2005. The cause of death 
considered for the study was AMI (ICD-9:410; ICD-10: 
I21). This was presented in three age groups: 0–64 years, 
65–74 years, and 75 years and above. There was no sex 
distribution provided.
Age-specific mortality rates were also calculated for each 
age group. The daily, monthly and yearly mortality rates 
were calculated, and the age-specific population served 
as denominator. The population data for each year and 
each age group were extracted from ONS yearly publi-
cations. The monthly rates were standardised to 30-day 
months.
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Adjustments in mortality rates were also made to 
account for changes in ICD coding. This was done using 
this formula: MA (y, d)=MO (y, d). R. MA is the adjusted 
daily mortality (deaths) for a day, d, in year, y. MO is 
the observed mortality. R is the comparability ratio: the 
ICD-10/ICD-9 comparability ratio for AMI 0.9889 was 
used to adjust ICD-9 code death counts.29
Specifically, the concept of excess winter deaths was 
explored in this study. The method used to analyse the 
excess winter deaths was first described by Curwen, 
and it is similar to that used by the ONS.30 The months 
of December–March defines the winter period. The 
non-winter period is defined as the months of August–
November before this winter period, and the months of 
April–July following the winter period.
In order to quantify the seasonal variation in winter, the 
excess winter mortality (EWM), EWM ratio (EWMR) and 
the EWM Index (EWMI) for each year were calculated. 
The EWM reflects the absolute difference in mortality 
between the winter season and non-winter season. 
Whereas the EWMR represents the relative risk of death 
during the winter months compared with the non-winter 
months. The EWMI represents a variant of relative risk 
reduction or ‘excess’. The EWMR and EWMI are viable 
tools for comparisons between age, sex, regions or 
countries. These estimates were also calculated for each 
age group. These estimates were calculated using the 
following formulae:
 Ź EWM=O–E
 Ź EWMR=O/E
 Ź EWMI = (O–E)/E or EWMR-1 (represented as a 
percentage)
Where, O is the observed death count. This is the total 
death counts during the winter months, a period of 4 
months (winter deaths). E is the expected death count 
which is the total death counts during the non-winter 
months, a period of 8 months, divided by 2.
Direct correlation between mean monthly tempera-
ture and monthly mortality rate was carried out with a 
significance level set at <0.05. Addition trend analysis 
with autoregressive integrated moving average model and 
forecasting was done with a significance level <0.05.
A regression model was used in assessing the rates of 
death during the winter season and non-winter seasons. 
The log-linear model was derived with the mortality count 
during winter period as the estimated outcome while age 
was the explanatory variable. The hypothesis was to test 
if there was any difference between EWMRs among the 
various age groups. Therefore, the log of the average 
non-winter deaths was used as offset to fit the model. The 
model was fitted using a negative binomial model with a 
log-link function due to overdispersion in the initial anal-
ysis. All analyses were carried out using SPSS V.19. Signif-
icant p value was defined as <0.05.
Patient and public involvement
Patients and public were not involved in the design study.
results
Between August 1997 and July 2005, there were 359 408 
deaths due to AMI with an average death count of 44 926 
occurring yearly (table 1). Of the total deaths, 62.7% 
were seen in the age group 75 years and above, 23.1% in 
the age group 65–74 years and 14.2% in the age group 
0–64 years. A steady decline in the absolute death counts 
and mortality rates were seen in all age groups across the 
years (figure 1). Overall, the decline in mortality rate for 
AMI was 6.8% yearly between August 1997 and July 2005.
A sharp rise in mortality is noticed in early November 
and peaks between December and January (figure 2). 
A second rise also occurs around the month of March 
but the mortality rate seen during this period is not as 
high as that observed during the December and January 
months. The lowest mortality rates occurred during July 
and August months.
A plot of the mean temperatures in Celsius (figure 3) 
showed a trough during the months of December to 
Table 1 Yearly mortality patterns of acute myocardial infarction from August 1997 to July 2005
Year period*
Mortality rate per 10 000 (number of deaths)
Age: 0–64 years Age: 65–74 years
Age: 75 years and 
above Total
1997/1998 1.96 (8184) 24.72 (14299) 83.59 (33678) 10.87 (56161)
1998/1999 1.81 (7581) 22.59 (13119) 79.84 (32283) 10.22 (52983)
1999/2000 1.64 (6924) 20.11 (11724) 74.70 (30330) 9.41 (48978)
2000/2001 1.52 (6435) 17.99 (10528) 67.98 (27716) 8.55 (44679)
2001/2002 1.40 (5964) 16.28 (9567) 65.00 (26610) 8.03 (42141)
2002/2003 1.35 (5784) 14.71 (8685) 64.45 (26495) 7.77 (40964)
2003/2004 1.21 (5189) 13.39 (7937) 60.84 (25125) 7.22 (38251)
2004/2005 1.16 (5005) 11.84 (7066) 55.79 (23180) 6.62 (35251)
Total 1.51 (51066) 17.70 (82925) 69.02 (225417) 8.59 (359408)
*Year period is August the previous year to July the next year. E.g. Year period 1997/1998 is August 1997 to July 1998.
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March and when compared with figure 2, this indicates 
that lower temperatures are observed during the peaks 
of mortality during the year. A plot of the mean monthly 
temperature with mortality rate showed a significant 
negative correlation between the two variables (r=−0.48; 
p<0.0001).
estimation of eWM due to AMI
EWM was seen in all the years observed. An average of 
about 2463 excess winter deaths occurred yearly. In all 
year periods, the highest absolute EWM occurred in 
those 75 years and above (table 2). This age group also 
contributed an average of 70% to the excess winter 
deaths yearly. The EWM over the 8-year period resulted 
in 19 635 total deaths. This is equivalent to 5.5% of the 
overall yearly mortality due to AMI over the 8-year period.
The EWMR (winter:non-winter rate ratio) is greater than 
one in all year periods considered, indicating that there is 
greater mortality in winter compared with the non-winter 
months (table 3). The EWMR describes the risk in dying 
during winter compared with non-winter months. This can 
also be represented as a percentage (EWMI). This shows 
that there is an average 17% excess death yearly (table 2).
Figure 1 A steady decline in mortality rate due to acute myocardial infarction over the year periods.
Figure 2 Showing variation in mortality rate over the months over the year periods.
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A regression analysis was carried out using a negative 
binomial regression to estimate the EWMR and age 
(table 4). The relative risk of excess mortality in age 
groups 65–74 years and 75 years and above was 1.36 and 
2.45, respectively, compared with the younger age group.
Figure 4 shows the trend of mortality rate and EWMI 
secondary to AMI. There is a steady decline in mortality 
rate with a significant trend for reduction in AMI-as-
sociated mortality observed over the period studied 
(p<0.001). The forecast for the next 11-year periods shows 
a continued decline. The forecast for the EWMI shows no 
change and remains relatively the same (p<0.001).
dIsCussIOn
The results from the data analysis showed that there is a 
significant increase in mortality rates due to AMI during 
the winter period in England and Wales. In this study, the 
EWMR over the 8-year study period for all age groups was 
1.17 with a resultant 17% excess winter deaths for AMI. 
This amounted to about 20 000 excess deaths due to this 
disease. From their analysis of 2266 deaths, Biedrzycki 
and Baithun1 in their study of mortality from myocardial 
infarction found that December was the peak month of 
mortality. A decline was observed from February onwards 
with the lowest mortality rate observed during the month 
of August. This pattern is similar to what was elicited in 
this paper: the highest mortality rates peaked between 
December and January, and lowest mortality rates were 
observed during the months of July and August. Besides 
the demonstrable winter excess, the monthly mortality 
rate plot showed a double peak. A peak in mortality, 
which was clearly above the mean mortality rate, was 
Figure 3 A plot of the mean monthly temperatures in Celsius with an obvious dip in temperatures during the months of 
December to March.
Table 2 Excess winter mortality and index secondary to AMI between 1997 and 2005
Year period
EWM (EWMI)
Age: 0–64 years, n (%) Age: 65–74 years, n (%) Age: 75 years +, n (%) Total, n (%)
1997/1998 244.5 (9) 731.5 (16) 1716.0 (16) 2692.0 (15)
1998/1999 281.5 (12) 756.0 (18) 2280.0 (23) 3317.5 (20)
1999/2000 333.0 (15) 643.5 (17) 2715.0 (29) 3691.5 (24)
2000/2001 148.5 (7) 368.5 (11) 1332.5 (15) 1849.5 (13)
2001/2002 258.0 (14) 453.0 (15) 1372.5 (16) 2083.5 (16)
2002/2003 196.5 (11) 423.0 (15) 1430.0 (17) 2049.5 (16)
2003/2004 251.0 (15) 260.0 (10) 1339.5 (17) 1850.5 (15)
2004/2005 140.5 (9) 466.0 (21) 1494.5 (21) 2101.0 (19)
Total 1853.5 (11) 4101.5 (16) 13 680.0 (19) 19 635.0 (17)
AMI, acute myocardial infarction; EWM, excess winter mortality; EWMI, EWM Index. 
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observed around the month of March. This second peak 
in mortality was less than that seen in the months of 
December and January.
Since fluctuations in daily temperatures could not be 
appreciated from monthly mean temperature data, it is 
possible that absolute low outdoor temperatures may not 
be the only factor in causing mortality but rather daily 
changes in temperature may also be significant. It has 
already been established that in most countries in Europe 
a 1°C drop in temperature is associated with increase 
in mortality.12 13 Carson et al in their study found that 
cardiovascular diseases were more sensitive to tempera-
ture changes than respiratory disease.31 This relationship 
has also been recognised in other studies: Kysely et al14 
found that fluctuations in daily temperatures resulted 
in increase in mortality rates of cardiovascular diseases. 
They also noted that a second cold spell usually had a 
lower excess mortality and suggested that the reason for 
this might be that some form of acclimatisation to the 
previous cold spell might be protective against the next. 
This might explain the double peaks that were observed 
in this study. Large variations in temperatures between 
winter and non-winter months as seen in countries with 
warm winters such as England and Wales may also explain 
the winter paradox observed in Europe. It is possible 
that the lack of acclimatisation due to the non-persistent 
cold weather, unlike in Iceland and Russia, may lead to 
a greater impact when the winter season does arrive. 
However, this is not conclusive and would require more 
research to clearly define such an association.
The study has shown that AMI has undergone a steady 
decline in England and Wales over the years. This is 
remarkable. The decline of mortality rate from 10.87 
deaths per 100 000 population to 6.62 deaths per 10 000 
population was observed over the 8-year study period. 
This was statistically significant. The reasons for this may 
include such factors as better diagnostic and therapeutic 
procedures, healthier life styles of the population and 
better awareness of the public. Despite this steady decrease 
in total yearly mortality rate, the risk of dying from AMI 
during winter has remained the same. This is suggestive 
that EWM is not a function of the overall mortality. This 
has important control and prevention implications: the 
measures used to control overall mortality may not neces-
sarily influence winter excess.
One of such measures could be vitamin D supplemen-
tation. There are several factors which could be possibly 
associated with EWM, and this may include seasonal vari-
ations in solar UVB doses and serum 25-hydroxyvitamin D 
[25(OH)D] concentrations, temperature and humidity.28 
Among these factors, possibly 25(OH)D concentration 
(<20 ng/mL) would be a modifiable risk factor, and its 
supplementation to levels greater than 36 ng/mL might 
reduce death rates significantly in winter months. In 
a Study in Iran,32 supplementation of vitamin to levels 
greater than 20 ng/mL was effective in reducing the 
cholesterol level by about 16 mg/dL. The clinical signifi-
cance of this result needs to be investigated. Several clin-
ical trials as well as observational and ecological studies 
are ongoing, and these will provide results to clarify 
whether vitamin D deficiency is a modifiable factor to 
prevent cardiovascular disease.
There was a gradient relationship between excess 
winter deaths and age: we found increasing winter deaths 
Table 3 Excess winter mortality ratio secondary to acute myocardial infarction between 1997 and 2005
Year period
Excess winter mortality ratio (CI)
Age: 0–64 years Age: 65–74 years Age: 75 years + Total
1997/1998 1.09 (1.07 to 1.11) 1.16 (1.15 to 1.18) 1.16 (1.15 to 1.17) 1.15 (1.14 to 1.16)
1998/1999 1.12 (1.09 to 1.14) 1.18 (1.17 to 1.20) 1.23 (1.22 to 1.24) 1.20 (1.19 to 1.21)
1999/2000 1.15 (1.13 to 1.17) 1.17 (1.16 to 1.19) 1.29 (1.28 to 1.31) 1.24 (1.24 to 1.25)
2000/2001 1.07 (1.05 to 1.09) 1.11 (1.09 to 1.13) 1.15 (1.14 to 1.16) 1.13 (1.12 to 1.14)
2001/2002 1.14 (1.11 to 1.16) 1.15 (1.13 to 1.17) 1.16 (1.15 to 1.17) 1.16 (1.15 to 1.17)
2002/2003 1.11 (1.08 to 1.13) 1.15 (1.13 to 1.17) 1.17 (1.16 to 1.18) 1.16 (1.15 to 1.17)
2003/2004 1.15 (1.13 to 1.18) 1.10 (1.08 to 1.12) 1.17 (1.16 to 1.18) 1.15 (1.14 to 1.16)
2004/2005 1.09 (1.06 to 1.11) 1.21 (1.19 to 1.23) 1.21 (1.19 to 1.22) 1.19 (1.18 to 1.20)
All periods 1.11 (1.10 to 1.13) 1.16 (1.14 to 1.17) 1.19 (1.18 to 1.20) 1.17 (1.17 to 1.18)
Table 4 Excess winter mortality ratio and age
Age Coeficient EWM (%) Relative risk P values
0–64 years reference 11
65–74 years 0.31 16 1.36 (1.18–1.57) <0.0001
75 years + 0.89 19 2.45 (2.16–2.77) <0.0001
EWM, excess winter mortality.
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with increasing age. A regression model was used to esti-
mate the relationship between age and winter mortality, 
and we found a more than twofold increase in risk when 
the oldest age group was compared with the youngest. 
The older age groups seem to be more vulnerable to the 
effects of winter and should be an important risk targeted 
group for prevention policies and strategies.
The excess winter paradox observed across countries in 
Europe and the identified decline in winter deaths seen in 
some countries suggest that significant increases in death 
during winter are preventable. The decline observed in 
EWM in all age groups, as well as overall, observed during 
the 2000–2001 year is interesting. This period had the lowest 
EWMR and also observed the highest percentage drop in 
EWMR. It also had the least absolute excess winter death 
counts among all the year periods studied. A few months 
earlier, the UK Government introduced innovative measures 
to tackle the burden of winter excess deaths. These measures 
were robust interventions incorporated in the fuel poverty 
strategy. This sharp drop in EWMR may suggest that these 
measures may have had an immediate impact. However, 
this study cannot conclusively confirm this. Nevertheless, if 
these strategies had an immediate impact, it was definitely 
short-lived. This is because despite the fluctuations the 
trend has remained the same. In other words, the increased 
risk of dying during winter due to AMI has remained high 
in England and Wales despite the various strategies imple-
mented by the government, and the trend analysis shows 
that it will remain so for a couple of years. It might be that it 
is too soon to evaluate the impact of these measures or they 
may not be effective.
The results of this study can be generalised to any popu-
lation where significant winter occurs, and an assump-
tion can be made that a significant winter is when the 
temperature drops below 18°C over a defined period. As 
elucidated in the preceding paragraphs, this has been 
observed in various countries in Europe, America and 
Asia. However, the impact in winter mortality may vary 
from society to society because of other ecological factors 
such as behavioural, housing and immunisation practices.
This study was a secondary data analysis, and it faced 
certain limitations. Although the data provided by the 
ONS were complete and considered accurate, the data 
characteristics however restricted the number of vari-
ables that could be controlled such as sex distribution. 
To reach a more robust conclusion, it would have been 
necessary to have data to test for effects of housing, 
indoor temperatures, outdoor temperatures, influenza 
epidemics and other possible confounders. It has been 
identified in existing literature that these factors play a 
part in the complex mechanism that brings about EWM. 
It would have been appropriate to adjust for their effects. 
Figure 4 Trend in mortality rate and EWMI over the year period observed and forecast for the next 11 years. There is a steady 
decline in mortality rate with a signiicant trend for reduction in AMI-associated mortality. The forecast for the next 11-year 
period shows a continued decline. The forecast for the EWMI shows no change. AMI, acute myocardial infarction; EWMI, 
Excess Winter Mortality Index. 
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Also, the population data which was used as denominator 
would reduce in accuracy as the year of study moved away 
from the recent census (29 April 2001). This is because 
the mid-year populations after this date were extrapo-
lated using birth and death data; these data are prone to 
their own type of error. However, it is anticipated that the 
brief period used in the research was unlikely to experi-
ence any dramatic changes in population. The method 
used in this study to estimate EWM was first described 
by Curwen,4 and this method defines the winter period 
between December and January. It has an advantage 
because these months have constantly shown mortality 
rates greater than the mean monthly mortality rates. 
It is essential to note this method of assessment when 
comparing future studies on EWM as other studies may 
use calendar winter months in their analysis.
COnClusIOn
This study has shown that increased winter mortality due to 
AMI does exist. The EWM has remained high for AMI for 
England and Wales over the years. The study also identified 
an association between increasing age and increasing EWM. 
There is a possibility that acclimatisation may play a role in 
the mechanisms that initiate winter deaths.
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